#Liquid_Biopsy
LightNews LightNews
newsen.bsky.social
Caris Life Sciences Introduces an Advanced Liquid Biopsy Solution to Revolutionize Cancer Treatment Decisions#USA#Caris_Life_Sciences#Liquid_Biopsy#Irving#Caris_Assure
Caris Life Sciences Introduces an Advanced Liquid Biopsy Solution to Revolutionize Cancer Treatment Decisions
Caris Life Sciences has launched the enhanced Caris Assure, a new evolution in liquid biopsy technology offering deeper molecular insights for precision oncology.
third-news.com
September 29, 2026 at 10:33 AM
newsen.bsky.social
Pillar Biosciences and AstraZeneca Enhance Liquid Biopsy Accessibility in China#China#Shanghai#AstraZeneca#Liquid_Biopsy#Pillar_Biosciences
Pillar Biosciences and AstraZeneca Enhance Liquid Biopsy Accessibility in China
Pillar Biosciences and AstraZeneca have announced an expansion of their liquid biopsy partnership in China, enhancing access to genomic insights for cancer patients.
third-news.com
December 8, 2025 at 3:12 PM
newsen.bsky.social
SOPHiA GENETICS Revolutionizes Liquid Biopsy Testing with MSK-ACCESS® Adoption#USA#Boston#Liquid_Biopsy#SOPHiA_GENETICS#MSK-ACCESS
SOPHiA GENETICS Revolutionizes Liquid Biopsy Testing with MSK-ACCESS® Adoption
SOPHiA GENETICS' MSK-ACCESS® for liquid biopsy testing gains traction globally, marking a significant advancement in oncology research and patient care.
third-news.com
February 24, 2025 at 9:02 AM
newsen.bsky.social
Senseera Secures $7.1 Million Funding to Transform Liquid Biopsy Diagnostics#Israel#Jerusalem#Liquid_Biopsy#Lightspeed#Senseera
Senseera Secures $7.1 Million Funding to Transform Liquid Biopsy Diagnostics
Senseera has successfully closed a $7.1 million seed funding round, led by Lightspeed Venture Partners, to enhance its innovative liquid biopsy technology.
third-news.com
January 7, 2025 at 7:02 AM
newsen.bsky.social
VolitionRx Achieves Major Breakthrough in Liquid Biopsy with Over 99% Cancer DNA Purity#United_States#Liquid_Biopsy#cancer_detection#VolitionRx#Henderson,_Nevada
VolitionRx Achieves Major Breakthrough in Liquid Biopsy with Over 99% Cancer DNA Purity
VolitionRx Limited makes significant strides in liquid biopsy technology, achieving over 99% purity in isolating cancer-derived DNA, paving the way for early detection.
third-news.com
March 18, 2026 at 12:42 PM
newsen.bsky.social
A.D.A.M. Innovations and SOPHiA GENETICS Partner to Enhance Liquid Biopsy Testing in Japan#Japan#Tokyo#Liquid_Biopsy#SOPHiA_GENETICS#ADAM_Innovations
A.D.A.M. Innovations and SOPHiA GENETICS Partner to Enhance Liquid Biopsy Testing in Japan
A.D.A.M. Innovations and SOPHiA GENETICS are collaborating to promote liquid biopsy testing and companion diagnostics for precision oncology in Japan, enhancing patient care.
third-news.com
October 17, 2025 at 1:58 PM
newsen.bsky.social
Advancing Precision Oncology: A.D.A.M. Innovations Teams Up with SOPHiA GENETICS for Liquid Biopsy Testing#Japan#Tokyo#Liquid_Biopsy#SOPHiA_GENETICS#A.D.A.M._Innovations
Advancing Precision Oncology: A.D.A.M. Innovations Teams Up with SOPHiA GENETICS for Liquid Biopsy Testing
A.D.A.M. Innovations and SOPHiA GENETICS join forces to enhance liquid biopsy testing for personalized cancer care in Japan, utilizing advanced AI technology.
third-news.com
October 16, 2025 at 3:45 PM
newsen.bsky.social
Innovative Collaboration Between Tethis and Sheba Medical Center to Enhance AI-Powered Liquid Biopsy for Rectal Cancer#Israel#Liquid_Biopsy#Tethis#Sheba_Medical#Tel_Hashomer
Innovative Collaboration Between Tethis and Sheba Medical Center to Enhance AI-Powered Liquid Biopsy for Rectal Cancer
Tethis S.p.A. and Sheba Medical Center join forces to advance the use of AI-driven liquid biopsy technology in rectal cancer treatment, aiming for precision medicine breakthroughs.
third-news.com
March 10, 2025 at 6:04 AM
newsen.bsky.social
Cancer Tumor Profiling Market to Surge to $19.87 Billion by 2031, Transforming Oncology Care#United_States#Liquid_Biopsy#Delray_Beach#Precision_Oncology#Cancer_Tumor_Profiling
Cancer Tumor Profiling Market to Surge to $19.87 Billion by 2031, Transforming Oncology Care
The Cancer Tumor Profiling Market is set to grow from $12.02 billion in 2026 to $19.87 billion by 2031, driven by precision oncology advancements.
third-news.com
August 12, 2026 at 2:29 PM
newsen.bsky.social
NIAID Awards $8.9 Million to Zepto Life for Innovative Liquid Biopsy Solutions#United_States#Liquid_Biopsy#St._Paul#FungiFlex#Zepto_Life
NIAID Awards $8.9 Million to Zepto Life for Innovative Liquid Biopsy Solutions
Zepto Life Technology secures a significant contract from NIAID to enhance its groundbreaking liquid biopsy platform, critical for diagnosing fungal infections.
third-news.com
August 11, 2026 at 2:44 PM
newsen.bsky.social
VolitionRx's First Peer-Reviewed Publication on Breakthrough Capture-Seq™ Technology#United_States#Liquid_Biopsy#Henderson#VolitionRx#Capture-Seq™
VolitionRx's First Peer-Reviewed Publication on Breakthrough Capture-Seq™ Technology
VolitionRx Limited has announced the publication of its first peer-reviewed paper detailing the innovative Capture-Seq™ liquid biopsy technology, which aims to transform early cancer detection.
third-news.com
August 5, 2026 at 12:29 PM
newsen.bsky.social
Zymo Research Partners with BLOODPAC to Enhance Liquid Biopsy Standards in Cancer Research#USA#Irvine#Liquid_Biopsy#Zymo_Research#BLOODPAC
Zymo Research Partners with BLOODPAC to Enhance Liquid Biopsy Standards in Cancer Research
Zymo Research has allied with BLOODPAC to enhance liquid biopsy assay standards, aiming to improve cancer detection and precision medicine.
third-news.com
June 30, 2026 at 2:09 PM
newsen.bsky.social
Revolutionary Liquid Biopsy Test Receives FDA Breakthrough Status for Mold Infections#United_States#Liquid_Biopsy#Saint_Paul#FungiFlex#Zepto_Life
Revolutionary Liquid Biopsy Test Receives FDA Breakthrough Status for Mold Infections
Zepto Life Technology's FungiFlex® Mold Panel gets FDA Breakthrough Device Designation, facilitating the diagnosis of invasive mold infections via liquid biopsy technology.
third-news.com
June 3, 2026 at 3:14 PM
newsen.bsky.social
Belay Diagnostics Summit's Impact on CNS Cancer Management Reaches 93% in New Study#USA#Chicago#Liquid_Biopsy#CNS_Cancer#Belay_Summit
Belay Diagnostics Summit's Impact on CNS Cancer Management Reaches 93% in New Study
A recent study revealed that Belay Summit's CSF liquid biopsy test informed clinical decisions in 93% of CNS cancer cases, enhancing diagnosis and treatment.
third-news.com
May 6, 2026 at 3:57 PM
newsen.bsky.social
New Study Reveals CSF Liquid Biopsy's Potential in Diagnosing Leptomeningeal Disease#USA#Chicago#Liquid_Biopsy#Belay_Diagnostics#Leptomeningeal_Disease
New Study Reveals CSF Liquid Biopsy's Potential in Diagnosing Leptomeningeal Disease
A recent study shows that CSF liquid biopsy could be a game changer in diagnosing leptomeningeal disease, addressing previous inconclusive findings.
third-news.com
April 14, 2026 at 3:25 PM
newsen.bsky.social
PanGIA Biotech's Innovative Study Utilizes Machine Learning for Prostate Cancer Detection via Urine-Based Biopsy#United_States#Liquid_Biopsy#Delray_Beach#Prostate_Cancer#PanGIA_Biotech
PanGIA Biotech's Innovative Study Utilizes Machine Learning for Prostate Cancer Detection via Urine-Based Biopsy
PanGIA Biotech has released a groundbreaking study demonstrating a 97.8% sensitivity for detecting prostate cancer using machine learning with urine biopsies, emphasizing earlier diagnosis.
third-news.com
April 2, 2026 at 11:42 AM
newsen.bsky.social
Significant Growth Expected in Exosome Diagnostic and Therapeutics Market by 2032#None#Liquid_Biopsy#Precision_Medicine#Exosome_Diagnostics
Significant Growth Expected in Exosome Diagnostic and Therapeutics Market by 2032
The Exosome Diagnostic and Therapeutics Market is projected to reach USD 401.70 million by 2032, fueled by advancements in liquid biopsy and precision medicine.
third-news.com
March 6, 2026 at 4:53 AM
newsen.bsky.social
Revolutionizing Liquid Biopsy: nRichDX and Hamilton's New Automated System#United_States#Liquid_Biopsy#Hamilton#Reno#nRichDX
Revolutionizing Liquid Biopsy: nRichDX and Hamilton's New Automated System
Explore the partnership between nRichDX and Hamilton that aims to enhance liquid biopsy sample preparation with powerful automation and unmatched yield.
third-news.com
January 27, 2026 at 2:42 PM
newsen.bsky.social
New Standards Introduced for Liquid Biopsy Tests Monitoring Cancer Recurrence#USA#Chicago#Liquid_Biopsy#Cancer_Recurrence#BLOODPAC
New Standards Introduced for Liquid Biopsy Tests Monitoring Cancer Recurrence
The BLOODPAC Consortium has published a new document detailing standards for liquid biopsy tests in JCO Precision Oncology, aiming to enhance cancer care.
third-news.com
January 15, 2026 at 12:20 PM
newsen.bsky.social
BLOODPAC Sets New Standards for Liquid Biopsy Tests to Monitor Cancer Recurrence#USA#Chicago#Liquid_Biopsy#Cancer_Recurrence#BLOODPAC
BLOODPAC Sets New Standards for Liquid Biopsy Tests to Monitor Cancer Recurrence
BLOODPAC has published new standards for liquid biopsy tests aimed at monitoring cancer recurrence. This framework enhances test validation and patient care.
third-news.com
January 15, 2026 at 12:17 PM
newsen.bsky.social
VolitionRx Unveils Groundbreaking Technique for Liquid Biopsy with 180-Fold Enrichment#United_States#Liquid_Biopsy#Henderson#VolitionRx#Capture-Seq
VolitionRx Unveils Groundbreaking Technique for Liquid Biopsy with 180-Fold Enrichment
VolitionRx has introduced a revolutionary method to enhance liquid biopsy, achieving astounding 180-fold enrichment that could change cancer detection forever.
third-news.com
December 11, 2025 at 2:45 PM
newsen.bsky.social
GC Genome's Study Uncovers Key Confounders Affecting Cancer Signal Detection in Liquid Biopsy#South_Korea#Liquid_Biopsy#Yongin#cancer_detection#GC_Genome
GC Genome's Study Uncovers Key Confounders Affecting Cancer Signal Detection in Liquid Biopsy
A new study by GC Genome reveals critical physiological factors influencing cfDNA signals, paving the way to enhance liquid biopsy accuracy.
third-news.com
December 9, 2025 at 7:07 AM
newsen.bsky.social
Wobble Genomics Unveils Innovative Liquid Biopsy Technology at ESMO 2025#United_Kingdom#Cancer_Diagnosis#Liquid_Biopsy#Edinburgh#Wobble_Genomics
Wobble Genomics Unveils Innovative Liquid Biopsy Technology at ESMO 2025
Wobble Genomics showcased groundbreaking advancements in cancer diagnostics at ESMO 2025, featuring a sensitive liquid biopsy platform for RNA detection.
third-news.com
October 17, 2025 at 2:40 PM
newsen.bsky.social
A.D.A.M. Innovations and SOPHiA GENETICS Unite to Revolutionize Liquid Biopsy Testing in Japan#Japan#Tokyo#Liquid_Biopsy#SOPHiA_GENETICS#ADAM_Innovations
A.D.A.M. Innovations and SOPHiA GENETICS Unite to Revolutionize Liquid Biopsy Testing in Japan
A.D.A.M. Innovations and SOPHiA GENETICS collaborate to enhance liquid biopsy testing and precision oncology in Japan, making advanced diagnostics accessible.
third-news.com
October 16, 2025 at 3:47 PM
newsen.bsky.social
AccuGenomics and 1Cell.Ai Join Forces to Advance Liquid Biopsy Testing in Asia#United_States#Liquid_Biopsy#Wilmington #1Cell.Ai#AccuGenomics
AccuGenomics and 1Cell.Ai Join Forces to Advance Liquid Biopsy Testing in Asia
A new partnership between AccuGenomics and 1Cell.Ai aims to enhance liquid biopsy testing across Asia, expanding to the U.S. in the future.
third-news.com
October 13, 2025 at 12:51 PM